Illusion
From Halopedia, the Halo wiki
"WE'VE GOT A NEW CONTACT, UNKNOWN CLASSIFICATION!" This article may contain information based upon upcoming, unreleased, or recently-released content from Halo Infinite, and may not be fully complete. Additionally, the information may be subject to change if it is based on pre-release material. Please update it as soon as any relevant and accurate material is available.
|
Illusion | |
---|---|
Map overview | |
Game: |
|
Lore information | |
Location: |
|
Gameplay overview | |
Terrain: |
Human structure interiors[2] |
Map layout: |
Symmetrical[2] |
Recommended number of players: |
8 |
Illusion is a symmetrical multiplayer arena map coming to Halo Infinite with Content Update 29.[2]
Universe and lore
Illusion is set within the Office of Naval Intelligence's abandoned Ilex Facility where experiments on Covenant active camouflage and overshield technologies are conducted.[1][2]
Overview
Layout
Illusion is a symmetrical maps with a high degree of verticality. The map features three primary routes, with the central corridor featuring a gimmick where an energy field within the corridor switches between projecting active camouflage and overshield. Any players within the corridor will have either active camouflage and overshield applied to them, depending on which is active at the time. Displays can be found throughout the map which indicate when each will activate. The exterior corridors feature man cannons to launch players to the opposite corridors.[2]
Callouts
The following are locations on the map that are so named on the player's heads-up display during gameplay:
- This section needs expansion. You can help Halopedia by expanding it.
Production notes
- This section needs expansion. You can help Halopedia by expanding it.
Gallery
343 Industries employees showing off Illusion during a livestream.
Sources
- ^ a b Halo Waypoint, Map Overview - Halo Infinite CU29 (Retrieved on Jan 24, 2024) [archive]
- ^ a b c d e YouTube - HALO, January Update & HCS 2024 Roadmap | Halo Infinite (Retrieved on Jan 19, 2024)